MARKET WIRE NEWS

3 Stocks Poised to Disrupt the Healthcare Market by 2030

Source: Motley Fool

2026-05-08 07:50:00 ET

The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental drug development, slow adoption, and predictable revenue curves. But that's not what's on the horizon.

Healthcare is now shifting toward data-driven, high-efficacy, and platform-based models. Instead of blockbuster drugs built on broad patient populations and incremental efficacy, the system is moving toward precision, genomic data, real-world evidence, and artificial intelligence (AI) that may determine which patients get which therapies, and why.

Image source: Getty Images.

Continue reading

Recursion Pharmaceuticals Inc.

NASDAQ: RXRX

RXRX Trading

15.85% G/L:

$3.91 Last:

28,185,858 Volume:

$3.44 Open:

COSM Ad 300

RXRX Latest News

RXRX Stock Data

$2,001,374,702
484,488,629
1.68%
137
N/A
Biotechnology & Life Sciences
Healthcare
US
Salt Lake City

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App